The Vascular Study Group of New England Cardiac Risk Index (VSG-CRI) predicts cardiac complications more accurately than the Revised Cardiac Risk Index in vascular surgery patients  by Bertges, Daniel J. et al.
From the New England Society for Vascular Surgery
The Vascular Study Group of New England
Cardiac Risk Index (VSG-CRI) predicts cardiac
complications more accurately than the Revised
Cardiac Risk Index in vascular surgery patients
Daniel J. Bertges, MD, RVT,a Philip P. Goodney, MD,b Yuanyuan Zhao, MD,b Andres Schanzer, MD,c
Brian W. Nolan, MD,b Donald S. Likosky, PhD,b Jens Eldrup-Jorgensen, MD,d and
Jack L. Cronenwett, MD,b for the Vascular Study Group of New England, Burlington, Vt; Lebanon, NH;
Worcester, Mass; and Portland, Me
Objective: The Revised Cardiac Risk Index (RCRI) is a widely used model for predicting cardiac events after noncardiac
surgery. We compared the accuracy of the RCRI with a new, vascular surgery-specific model developed from patients
within the Vascular Study Group of New England (VSGNE).
Methods: We studied 10,081 patients who underwent nonemergent carotid endarterectomy (CEA; n  5293), lower
extremity bypass (LEB; n  2673), endovascular abdominal aortic aneurysm repair (EVAR; n  1005), and open
infrarenal abdominal aortic aneurysm repair (OAAA; n  1,110) within the VSGNE from 2003 to 2008. First, we
analyzed the ability of the RCRI to predict in-hospital major adverse cardiac events, includingmyocardial infarction (MI),
arrhythmia, or congestive heart failure (CHF) in the VSGNE cohort. Second, we used a derivation cohort of 8208 to
develop a new cardiac risk prediction model specifically for vascular surgery patients. Chi-square analysis identified
univariate predictors, and multivariate logistic regression was used to develop an aggregate and four procedure-specific
risk prediction models for cardiac complications. Calibration and model discrimination were assessed using Pearson
correlation coefficient and receiver operating characteristic (ROC) curves. The ability of the model to predict cardiac
complications was assessed within a validation cohort of 1873. Significant predictors were converted to an integer score
to create a practical cardiac risk prediction formula.
Results: The overall incidence of major cardiac events in the VSGNE cohort was 6.3% (2.5% MI, 3.9% arrhythmia, 1.8%
CHF). The RCRI predicted risk after CEA reasonably well but substantially underestimated risk after LEB, EVAR, and
OAAA for low- and higher-risk patients. Across all VSGNE patients, the RCRI underestimated cardiac complications by
1.7- to 7.4-fold based on actual event rates of 2.6%, 6.7%, 11.6%, and 18.4% for patients with 0, 1, 2, and>3 risk factors.
In multivariate analysis of the VSGNE cohort, independent predictors of adverse cardiac events were (odds ratio [OR])
increasing age (1.7-2.8), smoking (1.3), insulin-dependent diabetes (1.4), coronary artery disease (1.4), CHF (1.9),
abnormal cardiac stress test (1.2), long-term -blocker therapy (1.4), chronic obstructive pulmonary disease (1.6), and
creatinine >1.8 mg/dL (1.7). Prior cardiac revascularization was protective (OR, 0.8). Our aggregate model was well
calibrated (r 0.99, P< .001), demonstrating moderate discriminative ability (ROC curve 0.71), which differed only
slightly from the procedure-specific models (ROC curves: CEA, 0.74; LEB, 0.72; EVAR, 0.74; OAAA, 0.68). Rates of
cardiac complications for patients with 0 to 3, 4, 5, and >6 VSG risk factors were 3.1%, 5.0%, 6.8%, and 11.6% in the
derivation cohort and 3.8%, 5.2%, 8.1%, and 10.1% in the validation cohort. The VSGNE cardiac risk model more
accurately predicted the actual risk of cardiac complications across the four procedures for low- and higher-risk patients
than the RCRI. When the VSG Cardiac Risk Index (VSG-CRI) was used to score patients, six categories of risk ranging
from 2.6% to 14.3% (score of 0-3 to 8) were discernible.
Conclusions: The RCRI substantially underestimates in-hospital cardiac events in patients undergoing elective or urgent
vascular surgery, especially after LEB, EVAR, and OAAA. The VSG-CRI more accurately predicts in-hospital cardiac
events after vascular surgery and represents an important tool for clinical decision making. (J Vasc Surg 2010;52:674-83.)From the Divisions of Vascular Surgery of University of Vermont College of
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Volume 52, Number 3 Bertges et al 675cesses, but their accuracy and reliability may be reduced
when generic models are used for specific patient popula-
tions or procedures.
Patients undergoing vascular surgery are at risk for a
number of adverse outcomes, especially cardiovascular
events. Numerous attempts to predict cardiac risk before
noncardiac1-3 or vascular surgery4-10 have been conducted.
Currently, the most commonly used model is the Revised
Cardiac Risk Index (RCRI), which stratifies patients into
low-, intermediate-, and high-risk groups before elective,
noncardiac surgery.11,12 However, the RCRI was derived
from a heterogeneous patient population that included a
broad range of patients and surgical procedures, with only
a small subset of patients having undergone vascular sur-
gery. Therefore, the RCRI may not accurately predict
cardiac events in vascular surgery patients.
This study had two goals: The first was to test the
accuracy of the RCRI in predicting a composite cardiac
outcome of in-hospital myocardial infarction (MI), clini-
cally significant new arrhythmia, or congestive heart failure
(CHF) in patients undergoing nonemergent carotid end-
arterectomy (CEA), open infrarenal abdominal aortic an-
eurysm repair (OAAA), endovascular abdominal aortic an-
eurysm repair (EVAR), or lower extremity bypass (LEB).
The second was to develop an accurate, practical, and
comprehensive risk prediction model for this composite
outcome derived from patients in the Vascular Study
Group of New England (VSGNE).
METHODS
The Committee for the Protection of Human Subjects
at Dartmouth College reviewed and approved the research
analyses based on the VSGNE registry.
Patients and databases. We used data collected pro-
spectively by the VSGNE, a cooperative quality improve-
ment initiative developed in 2002 to study and improve
regional outcomes in vascular surgery. Further details on
this project have been published and are available at www.
vsgne.org.13
To obtain a broad sample of patient risk across a wide
spectrum of vascular procedures, we included the 10,081
patients who underwent nonemergent CEA, LEB, OAAA,
and EVAR between January 1, 2003, and January 1, 2008.
We also included 992 urgent operations, defined as occur-
ring 24 hours of admission before CEA, EVAR, or
OAAA and within 12 hours but 72 hours before LEB.
Symptomatic aneurysms (n  156) without rupture were
classified as urgent. The analysis excluded 368 emergency
operations, including ruptured AAA. Suprarenal open AAA
repairs and procedures for aortic occlusive disease were not
tracked in the VSGNE data set.
Definitions and outcome measures. As previously
described, 70 clinical and demographic variables were
collected for each patient and prospectively entered into
our registry.13,15 Coronary artery disease (CAD) was de-
fined as a history of MI, coronary revascularization, or
angina. Preoperative cardiac stress testing was obtained at
the clinician’s discretion and included the most recentstress electrocardiogram, stress echocardiogram, or nuclear
stress test 2 years.
Our main outcome measure was designed to mirror
that used by the RCRI and was defined as a composite of
in-hospital cardiac complications, including MI, clinically
significant arrhythmia, or CHF.Mortality was not included
in this end point to allow comparison with the RCRI,
which did not include this end point. MI was defined by
new ST and T wave changes, troponin elevation, or docu-
mentation by echocardiogram or other imaging modality.
Clinically significant arrhythmias included any new atrial or
ventricular rhythm disturbance requiring treatment with
medication or cardioversion. CHF included new pulmo-
nary edema documented by chest radiograph and requiring
treatment or monitoring in the intensive care unit. Long-
term -blocker therapy included medication started 1
month before surgery and perioperative -blockade in-
cluded treatment commenced 1 month before surgery.
Smoking included prior or current tobacco use.
Revised Cardiac Risk Index. The RCRI assigns a
score based on the following risk factors: (1) high risk
surgery defined as intraperitoneal, intrathoracic, or suprain-
guinal vascular procedures; (2) history of ischemic heart
disease; (3) history of CHF; (4) history of cerebrovascular
disease; (5) insulin-dependent diabetes; and (6) creatinine
2 mg/dL.11 These risk factors were found to predict a
combined end point of MI, pulmonary edema, ventricular
fibrillation or primary cardiac arrest, and complete heart
block. Risk scores are used to classify patients as low-risk
(0), intermediate-risk (1 to 2), or high-risk (3). The
expected rates of these major cardiac complications for
patients with 0, 1, 2, and3 risk factors are 0.4%, 0.9%, 7%,
and 11.1%.11
This composite end point and the risk factors that
predicted it were identified using variables in the VSGNE
data set. We excluded 272 patients (2.7%) because data on
one or more of the six RCRI predictor variables were not
available, leaving 9809 patients for analysis. Each outcome
measure and prediction variable were matched as closely as
possible between the VSGNE and RCRI. Four differences
were encountered in this process:
First, arrhythmia in RCRI includes only the incidence
of ventricular fibrillation or complete heart block, whereas
the VSGNE records clinically significant arrhythmia based
on any new rhythm disturbance requiring treatment with
medication or cardioversion.
Second, RCRI used pulmonary edema as the outcome,
whereas VSGNE used CHF, as defined previously. To
address these differences, our analysis was performed with
and without the presence of the arrhythmia and CHF
variables.
Third, in the RCRI, a history of cerebrovascular disease
(any prior stroke or transient ischemic attack) was identified
as a predictor of the main outcome measure. Although a
history of cerebrovascular disease was not specifically re-
corded in the VSGNE data set, we collected information
regarding the history of carotid surgery and substituted this
information accordingly.
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as a serum creatinine 1.8 mg/dL whereas the RCRI uses
a creatinine 2.0 mg/dL.
Analysis I: Comparison with RCRI. We evaluated
the incidence of the composite cardiac outcome measure as
defined by the RCRI in patients stratified according to the
number of RCRI risk factors they possessed. This calcula-
tion was performed for the entire cohort from 2003 through
2008 as well as for each specific operation subtype. Given that
the RCRI was designed to predict perioperative cardiac com-
plications, we calculated these rates at the time of discharge.
After we calculated the observed rates of the combined cardiac
outcome measure, we compared these rates with the rates
predicted by RCRI.
Analysis II: Development of a risk prediction model
for cardiac complications. To develop the VSGNE car-
diac risk model, the patient cohort was divided into a
derivation set of 8208 patients (81.4%) up to January 1,
2007, and a validation set of 1873 patients (18.6%) from
January 2007 to January 2008. The derivation and valida-
tion cohorts were comparable, with minor differences as
shown by univariate analysis (Appendix I, online only).
Although -blocker use was similar between cohorts, aspi-
rin and statin use was significantly higher in the validation
group.
To examine the possible affect of time on the derivation
and validation cohorts, we used a linear regression model
with observed/expected (O/E) ratio as a dependent vari-
able and year as the independent variable. There was no
statistically significant effect of year on the O/E ratio for
each model (aggregate, P  .136; CEA, P  .313; LEB,
P  .78; EVAR, P  .600; OAAA, P  .156).
To examine the risk factors associated with the com-
bined cardiac outcome measure, univariate comparisons of
demographic factors, comorbidities, medications, and sur-
gical variables were made between those who did or did not
experience cardiac complications. Risk factors found by
univariate analysis with a value of P  .1 were entered into
a backwards stepwise multivariate logistic regression
model. This model was then used to calculate odds ratios
(OR) and 95% confidence intervals (CI) for the risk of our
combined cardiac outcome measure. The discriminative
ability of the model was examined using receiver operating
characteristic (ROC) curves across differing groups of pa-
tient risk. To test the calibration of the model (Hosmer-
Lemeshow goodness-of-fit statistic), we tested the correla-
tion between the observed and expected events across the
strata of increasing patient risk. To evaluate differing risks
across procedures, we derived an aggregate model for the
entire cohort and also developed models for the four indi-
vidual procedures.
A simple scoring algorithm called the Vascular Study
Group Cardiac Risk Index (VSG-CRI) was created by
assigning weighted points to each statistically significant
predictor from the multivariate analysis. The weighted
point score was calculated by dividing each -coefficient of
the predictor by the lowest -coefficient (0.25) and round-
ing to the nearest integer value. The score that was gener-ated was used to stratify patients into one of six categories
of risk. We also developed prediction models based solely
on ORs and both methods fit the data well. Analyses were
performed using SAS 9.1 software (SAS Institute Inc, Cary,
NC).
RESULTS
Patient and operative characteristics of VSGNE pa-
tients in the derivation set, with univariate analysis of in-
hospital, composite cardiac complications, are reported in
Table I. Characteristics of patients from the original RCRI
derivation set are shown in gray for comparison.11 Com-
pared with the RCRI cohort, the VSGNE derivation group
was older, included more men, more insulin-dependent
diabetic patients, and more patients with renal insufficiency
(Table IA). The prevalence of CAD was similar, but the
VSGNE group had a higher rate of prior coronary revascu-
larization by coronary artery bypass grafting (CABG) or
percutaneous coronary intervention (PCI; 32% vs 9%; P 
.001).
Vascular operations comprised only 21% of procedures
in the RCRI derivation set and did not include EVAR
(Table IB). The VSGNE group included vascular opera-
tions exclusively, with CEA comprising 52% of cases. Most
LEBs (72%) were performed for critical limb ischemia, with
a higher associated incidence of cardiac events compared
with claudicant patients (10.1% vs 3.7%; P  .001).
As expected, VSGNE patients with existing CAD,
CHF, or an abnormal stress test had significantly more
cardiac complications (Table I). Advancing age and a his-
tory of smoking, insulin-dependent diabetes, hypertension,
COPD, or renal insufficiency were also associated with
more cardiac complications. Treatment with antiplatelet
agents or statins had no effect on cardiac complications.
Long-term -blocker treatment was associated with in-
creased cardiac events, whereas preoperative -blocker
treatment was associated with fewer cardiac complications.
Composite cardiac complications. Across the entire
VSGNE cohort (n  10,081) the composite outcome of
any in-hospital MI, CHF, or arrhythmia occurred in 632
(6.3%), and clinically significant arrhythmias occurred in
397 (3.9%), followed byMI in 256 (2.5%) and CHF in 179
(1.8%). Cardiac complication rates differed across the four
index procedures. Within the derivation set, the composite
cardiac outcome was observed in 2.8% (119 of 4267) after
CEA, 7.9% (174 of 2194) after LEB, 4.7% (37 of 783) after
EVAR, and 19.3% (186 of 964) after OAAA. Within the
validation set, the composite cardiac outcome was observed
in 3.3% (34 of 1026) after CEA, 9.0% (43 of 479) after
LEB, 3.2% (7 of 222) after EVAR, and 22.6% (33 of 146)
after OAAA.
Accuracy of RCRI in predicting cardiac events.
Across procedures and strata of risk, the RCRI consistently
underestimated the risk of composite cardiac complications
in VSGNE patients, especially those undergoing LEB,
EVAR, and OAAA (Table II). Although an increasing
RCRI score correlated with increasing degrees of adverse
cardiac events, the index underestimated risk by a factor of
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univariate analysis of in-hospital, composite cardiac complications, and comparison with the Revised Cardiac Risk Index
(RCRI) derivation set
Prevalence of variable in derivation set Cardiac complication rate, %b
P valuecRCRI (n  2893)a VSGNE (n  8208) If variable present If variable not present
A, Patient variables
Demographics, %
Male gender 47 65.9 6.3 6.9 .323
Age, %
60 . . . 16.8 3.4 7.1 .001
60-69 . . . 29.9 5.9 6.8 .162
70-79 35d 37.9 7.4 5.9 .009
80 . . . 15.5 8.8 6.1 .001
Caucasian race . . . 99 6.5 2.6 .169
Risk factors, %
Smoking (prior or current) . . . 82.6 6.7 5.3 .049
Diabetes
None . . . 66.4 6 7.6 .006
Non-insulin-dependent . . . 22.1 6.3 6.6 .673
Insulin-dependent 4 11.4 10 6 .001
Hypertension . . . 85.1 6.8 4.7 .005
CAD 33 36.3 9.4 4.9 .001
Prior CABG/PCI 9 32 7.3 6.1 .04
CHF 15 10.9 14.7 5.5 .001
Stress test
Not obtained . . . 55.1 4.7 8.7 .001
Normal result . . . 30.5 7.6 6 .007
Abnormal result 7 13.6 11.3 5.7 .001
COPD . . . 28.5 9.5 5.3 .001
Chronic renal insufficiency
Creatinine 1.8 mg/dL 4 8.7 12.9 6 .001
Dialysis . . . 2.7 13.5 6.3 .001
Any prior vascular surgery . . . 29.5 7.5 6.1 .02
Prior CEA . . . 11.8 7.3 6.4 .273
Cerebrovascular disease 11e . . . . . . . . . . . .
Medications, %
Aspirin . . . 77.1 6.4 6.8 .586
Clopidogrel . . . 12.2 7.2 6.4 .325
Statin . . . 64.5 6.4 6.7 .617
-blockers
None . . . 17.1 4.6 6.9 .002
Perioperative . . . 25.3 5.1 7 .003
Long-term . . . 57.5 7.7 4.9 .001
B, Operative variables
Procedures, No. (%)
CEA 154 (5) 4267 (52)
LEB 299 (10) 2194 (27)
EVAR . . . 783 (9)
OAAA repair 110 (4) 964 (12)
Aortobifemoral bypass 45 (1.5) . . .
CEA, %
Asymptomatic . . . 54 3.4 2.3 .031
Symptomatic . . . 46 2.3 3.4 .031
LEB claudication, % . . . 28 3.7 10.1 .001
CLI, % . . . 72 10.1 3.7 .001
AAA Size
5.5 cm . . . 33.5 9.5 14.8 .002
5.5-6.0 cm . . . 32.4 13 13 .995
6.0 cm . . . 34.1 16.6 11.2 .002
AAA, Abdominal aortic aneurysm; CABG, coronary artery bypass graft; CAD, coronary artery disease; CEA, carotid endarterectomy; CHF, congestive heart
failure; CLI, critical limb ischemia; COPD, chronic obstructive pulmonary disease; EVAR, endovascular abdominal aortic aneurysm repair; LEB, lower
extremity bypass; OAAA, open infrarenal abdominal aortic aneurysm; PCI, percutaneous coronary intervention.
aRCRI derivation set shown for comparison.11
bIncludes myocardial infarction, CHF and arrhythmia.
cP derived from 2 test for categoric variables, statistical significance at P  .05.
dRCRI only reported age if 70.
eRCRI defined as transient ischemic attack or stroke.
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index was more accurate in predicting cardiac events after
CEA for both low- and high-risk patients. However, the
RCRI significantly underestimated risk for both low- and
high-risk patients undergoing LEB, EVAR, and OAAA.
The RCRI underestimated risk for open AAA by threefold
in high-risk patients, where actual events occurred in more
than one-third of patients.
For the entire VSGNE cohort, the rates of MI alone for
patients with 0, 1, 2, and 3 RCRI risk factors were 1.4%,
2.5%, 5.0%, and 8.0% (data not shown). Thus, the RCRI
estimate for the composite end point was more indicative of
the rate of MI alone among patients undergoing vascular
surgery in VSGNE.
VSGNE cardiac risk model. In the derivation set,
pre-existing CAD, CHF, insulin-dependent diabetes, and
renal insufficiency were significant risk factors by multivar-
iate analysis in the VSGNE model (see Table III for ORs
and 95% CIs). The VSGNE model included the additional
risk factors of increasing age, smoking, COPD, abnormal
preoperative cardiac stress test, and long-term -blocker
treatment (Table III). Age 80 years had the greatest
effect (OR, 2.8l; 95% CI, 2.0-4.1; P  .001). Prior coro-
nary revascularization was associated with a reduced level of
postoperative cardiac complications (OR, 0.8; 95% CI,
0.7-1.0; P .038). Multivariate testing showed instituting
-blocker treatment before surgery did not translate into a
lower incidence of cardiac complications (OR, 1.0; 95% CI,
0.8-1.4; P  .817). Notably, treatment with antiplatelet
agents and statins was not significant in the univariate
analysis and was not part of themultivariate model. Patients
without noninvasive preoperative cardiac testing had a sig-
nificantly lower incidence of cardiac complications (OR,
0.6; 95% CI, 0.5-0.7; P  .001) than those who had a
preoperative stress test.
Procedure-specific cardiac risk models were individu-
ally derived for CEA, LEB, EVAR, and OAAA (Appendix
II, A, online only). The predictors of age, COPD, insulin-
dependent diabetes, CHF, and abnormal cardiac stress test
result overlapped between the aggregate and these four
individual models. Female gender and critical limb ischemia
were important independent predictors for LEB, but not in
the aggregate model. The significant variables, ORs, and
Table II. Revised Cardiac Risk Index (RCRI) predicted r
congestive heart failure, or arrhythmia) compared with act
RCRI risk
factors
No.
RCRI predicted
risk
%
Entire
cohort (n  9809)
CE
(n 
0 0.4 2.6 (104/4046) 1.5 (38
1 0.9 6.7 (238/3555) 3.5 (63
2 6.6 11.6 (181/1561) 5.6 (35
3 11.0 18.4 (119/647) 9.8 (19
CEA,Carotid endarterectomy; EVAR, endovascular abdominal aortic aneur
aneurysm.95% CIs for the four procedure-specific cardiac risk indicesare reported in Appendix II, A (online only). Conflicting
results were noted with statin usage, which was protective
in the CEA model (OR, 0.6; 95% CI, 0.4-0.9; P  .011)
but showed a trend toward increased risk in the LEBmodel
(OR, 1.3; 95% CI, 0.9-1.8; P  .166).
Accuracy of VSGNE model in predicting cardiac
events. When patients were categorized according to the
number of VSGNE risk factors, we noted escalating levels
f composite cardiac events (myocardial infarction,
vent rates for entire cohort after interventions
Actual event rates, % and No.
) LEB (n  2610)
EVAR
(n  988)
OAAA
(n  1096)
3) 4.6 (46/1009) 3.8 (20/524) N/A
0) 7.1 (59/833) 3.1 (10/323) 17.1 (106/619)
) 13.1 (60/459) 12.9 (15/116) 19.9 (71/357)
) 17.8 (55/309) 4.0 (1/25) 36.7 (44/120)
pair; LEB, lower extremity bypass;OAAA, open infrarenal abdominal aortic
Table III. Multivariate predictors of composite cardiac
outcome for Vascular Study Group of New England
derivation cohort (2003-2007)
Variable
Aggregate modela
(N  8,208)
P valuebOR 95% CI
Age . . . . . . .001
60 Ref . . . . . .
60-69 1.7 1.2-2.4 .003
70-79 2.1 1.5-3.0 .001
80 2.8 2.0-4.1 .001
Smoking 1.3 1.0-1.8 .041
Diabetes . . . . . . .04
None Ref . . . . . .
Non-insulin-dependent 1 0.8-1.3 .953
Insulin-dependent 1.4 1.1-1.9 .014
CAD 1.4 1.2-1.8 .001
CABG/PCI –0.8 0.7-1.0 .038
CHF 1.9 1.5-2.5 .001
COPD 1.6 1.3-1.9 .001
Creatinine1.8 mg/dL 1.7 1.3-2.2 .001
Cardiac stress test . . . . . . .001
Normal result Ref . . . . . .
Not obtained 0.6 0.5-0.7 .001
Abnormal result 1.2 1.0-1.6 .115
-Blockers . . . . . . .024
None Ref . . . . . .
Perioperative 1 0.8-1.4 .817
Long-term 1.4 1.0-1.8 .036
CABG, Coronary artery bypass graft; CAD, coronary artery disease; CHF,
congestive heart failure;CI, confidence interval;COPD, chronic obstructive
pulmonary disease; OR, odds ratio; PCI, percutaneous coronary interven-
tion.
aReceiver operating characteristic area under curve  0.71, Hosmer-Lemeshow
goodness-of-fit test was P  .580.
bStatistical significance at P  .05.isk o
ual e
A
5115
/251
/178
/629
/193
ysm reof the composite cardiac event rate across four risk strata:
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of patients within the four risk strata was similar between
the derivation (23%, 17%, 18%, and 42%) and validation
sets (23%, 18%, 19%, and 40%). The aggregate VSGNE
cardiac risk model accurately predicted the composite in-
hospital cardiac event rate in the validation cohort com-
pared with the derivation set. Rates of cardiac complica-
tions for patients with 0 to 3, 4, 5, and 6 VSGNE risk
factors were 3.1%, 5.0%, 6.8%, and 11.6% in the derivation
cohort and 3.8%, 5.2%, 8.1%, and 10.1% in the validation
cohort (P  .38, .89, .37, and .31). This aggregate model
was also a good predictor of cardiac risk when applied to
patients undergoing CEA, LEB, and aneurysm repair (data
not shown).
As outlined above, we evaluated the ability of both the
aggregate and procedure-specific models to discriminate
between patients likely and not likely to have an adverse
cardiac event. Overall, the aggregate and procedure-specific
models both had fair discriminative ability.When applied to
the derivation set, the aggregate, CEA, LEB, OAAA, and
EVAR model area under the ROC (AUROC) curve was
0.71, 0.74, 0.72, 0.74, and 0.68, respectively.14 When
applied to the validation set, the aggregate, CEA, LEB,
OAAA, and EVAR model AUROC curve was 0.66, 0.75,
0.72, 0.69, and 0.73 respectively (Appendix II, B, online
only).
Finally, to assess how our models performed across
strata of patient risk, we compared observed and expected
values between low- and high-risk patients. We found an
essentially linear relationship across quintiles of predicted vs
Fig 1. Vascular Study Group (VSG) of NewEngland de
of composite cardiac event rates (in-hospital myocardial in
factors include age, smoking, diabetes, coronary artery
coronary intervention, abnormal cardiac stress test resu
mg/dL, and long-term -blocker treatment. *All P va
respectively. Data are shown with the standard error.observed risk for the aggregate model (R2 0.99) and theprocedure-specific models (range of R2  0.96-0.99; Ap-
pendix III, online only).
The sensitivity, specificity, positive predictive, and neg-
ative predictive values for the aggregate model were 68%,
62%, 11%, and 97% respectively, corresponding to the cut
point 0.06. Appendix IV (online only) shows the values for
the procedural models.
The VSGNE Cardiac Risk Index. Using the nine
risk factors for the composite end point identified in our
multivariate model, we developed a risk score to facilitate
calculation of patient-level risk of cardiac complications
(Fig 2). Noninvasive cardiac testing was removed from the
model to provide a purely clinical risk prediction formula
applicable to all patients in the preoperative setting,
whether or not they had undergone stress test evaluation.
The VSG Cardiac Risk Index (CRI) formula predicted
increasing levels of risk for the composite cardiac end point,
ranging from 2.6% for the lowest risk (score 0-3), 6.0% to
6.6% for intermediate risk (score 5-6), and 8.9% to 14.3%
for the highest risk (score 7-8). Increasing decades of age
had the greatest effect on cardiac complications. Prior
CABG or PCI were inversely related to cardiac risk. The
VSG-CRI calculator is available online for each specific
procedure at www.vsgne.org.
DISCUSSION
Despite advances in perioperative care, cardiac compli-
cations remain a significant cause of morbidity and mortal-
ity after vascular surgery. Strategies to reduce cardiovascu-
lar complications have included preoperative coronary
on data set (2003-2007) vs the validation data set (2008)
ion, arrhythmia, or congestive heart failure [CHF]). Risk
e, CHF, coronary artery bypass grafting/percutaneous
hronic obstructive pulmonary disease, creatinine 1.8
ot significant by t test at .377, .890, .367, and .312,rivati
farct
diseas
lt, c
lues nrevascularization and perioperative medical management
us co
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tive coronary revascularization did not alter long-term sur-
vival in a large, randomized trial but resulted in improved
survival in a recent, smaller study.16,17 Recently, the effi-
cacy of perioperative -blockade in reducing cardiac events
has been questioned, especially for low- to intermediate-
risk patients.18,19 With such conflicting information, an
accurate clinical assessment of a patient’s cardiac risk re-
mains a critical initial step in treating patients with concom-
itant peripheral and coronary artery disease.
Since the original Goldman Cardiac Risk Index, multi-
ple studies have derived risk indices for noncardiac opera-
tions.1,2 The most widely applied is the RCRI, which was
derived from a wide variety of surgical procedures, includ-
ing orthopedic and thoracic.11 Vascular operations, includ-
ing LEB, CEA, and AAA repair, comprised only 21% of the
RCRI derivation cohort. We therefore questioned whether
the RCRI is applicable to patients undergoing peripheral
vascular operations, especially patients traditionally consid-
ered to be at higher risk, even though a review in the
Journal of Vascular Surgery recommended the RCRI for
use in vascular surgery patients.12
Study findings. This study is a large and comprehen-
sive analysis of the RCRI applied to vascular surgery per-
formed at academic and community hospitals that repre-
sent contemporary practice. We compared the RCRI’s
predictive ability for patients undergoing four index proce-
dures that represent a range of operative risk from low
(CEA) to high (OAAA repair).
This study also examined RCRI applicability to EVAR.
The RCRI predicted rates of major cardiac complications
for patients with 0, 1, 2, and3 risk factors was 0.4%, 0.9%,
7% and 11.1%.11 The RCRI closely matched the actual
Fig 2. Vascular Surgery Group Cardiac Risk Index (VS
events. CAD, Coronary artery disease; CHF, congestive
CABG, coronary artery bypass grafting, PCI, percutaneocardiac complications after CEA; however, it substantiallyunderestimated the risk after LEB, EVAR, and OAAA
across levels of low to high preoperative risk. The RCRI was
derived from a small subset (n  608/2893, 21%) of
patients who underwent a heterogenous group of vascular
surgery operations; thus, it is not surprising that the RCRI
did not predict cardiac risk as accurately as the VSG-CRI,
which was derived from a homogenous group of vascular
surgery operations.
It is important to note that a “low-risk” vascular sur-
gery patient in VSGNE has greater risk than a “low-risk”
patient in the general RCRI population. These results
imply that clinicians should use the RCRI with caution
when evaluating patients before vascular surgery. Recog-
nizing this limitation, we sought to develop a more accu-
rate and comprehensive cardiac risk prediction model that
was specific for the common vascular surgery operations.
The VSG-CRI more accurately predicted cardiac com-
plications after CEA, LEB, EVAR, and OAAA for both
low- and higher-risk groups. The aggregate VSGNEmodel
included age, smoking, insulin-dependent diabetes, CAD,
CHF, CABG/PCI, abnormal cardiac stress test result,
COPD, creatinine 1.8 mg/dL, and long-term -blocker
therapy. Four of these factors are included in the RCRI
(insulin-dependent diabetes, CAD, CHF, and renal insuf-
ficiency) and are important for vascular patient preoperative
assessment. Notably, non-insulin-dependent diabetes was
not associated with an increased risk of adverse cardiac
events. Accurate risk stratification of vascular surgery pa-
tients also requires the additional variables identified by the
VSG-CRI model (age, COPD, and long-term -blocker
therapy).
When the VSG-CRI was being developed, we consid-
ered the tradeoffs between an aggregate model that could
I) scoring system and predicted risk of adverse cardiac
failure; COPD, chronic obstructive pulmonary disease,
ronary intervention.G-CR
heartbe applied to all patients vs different procedure-specific
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individual models vs the aggregate model, but the differ-
ences in the ROC analysis were small. Thus, we concluded
that the aggregate VSG-CRI could be applied to a range of
patients undergoing CEA, LEB, EVAR, or OAAA without
sacrificing the predictive ability of the model. However, the
VSG-CRI model is available for each specific operation so
that individual patient risk can be automatically calculated
for each specific procedure (www.vsgne.org). The VSG-
CRI scoring system includes clinical variables that can be
readily calculated in the preoperative setting. Results of the
score stratify patients into low-, intermediate-, and high-
risk patients.
Prior attempts to predict preoperative cardiac risk have
included clinical risk prediction indices with or without
additional noninvasive cardiac testing. A significant num-
ber of our patients (55%) did not have preoperative stress
testing. Although our aggregate model included results of
cardiac stress testing, we decided to remove it from the
VSG-CRI score to provide a model reliant solely on clinical
variables. The decreased incidence of adverse cardiac events
in patients without preoperative noninvasive cardiac testing
appears to validate the clinician’s judgment about when to
perform such testing.
Although antiplatelet and statin agents did not appear
to reduce cardiovascular risk, most patients were taking
these medications, and it is likely that higher-risk patients
were treated, which would diminish the potential to detect
a real difference. Similarly, patients with long-term
-blocker treatment were likely treated due to higher car-
diac risk, thus accounting for the paradoxic observation
that such therapy is a marker for a higher risk of perioper-
ative cardiac complications in vascular surgery patients.
Previous analyses of the RCRI in vascular surgery.
Four studies have examined the accuracy of the RCRI in
vascular surgery patients. Karkos et al10 studied 77 elective
aortic reconstructions for aneurysmal or occlusive disease
and found some correlation between the RCRI and cardiac
morbidity.
In an analysis of 1998 cases, Press et al20 compared the
ability of different risk indexes to predict medical and
surgical complications after CEA. The RCRI accurately
predicted the 30-day rate of cardiac complications, includ-
ingMI, unstable angina, CHF, and ventricular tachycardia.
Cardiac complications occurred in 2.0%, 3.4%, 5.4%, and
7.9% of patients with 0, 1, 2, and 3 risk factors. We also
found the RCRI was relatively accurate in predicting car-
diac events after CEA. The observed events in the VSGNE
were strikingly similar to those reported in this earlier study,
given that a slightly higher complication rate would be
expected if we had included events out to 30 days.
Schouten et al21 found that larger AAA diameter was
associated with increased cardiac complications after elec-
tive OAAA repair. Of their 500 cases, 6.2% of patients
experienced 30-day cardiovascular death or nonfatal MI
without including arrhythmias. The ROC curve analysis in
their model showed a significantly improved AUROC
when AAA size and patient age were added. We reported acomposite adverse cardiac event rate of 20% after OAAA
repair. Unlike Schouten et al, AAA diameter was not im-
portant in our aggregate model or our specific OAAA
model, but AAA diameter was a significant predictor in our
EVAR model. We cannot explain this discrepancy, but
suspect it may be a limitation of the size of our data set.
Welten et al22 reported the importance of age and
hypertension as additional risk factors in 2642 patients after
open vascular surgery. The overall incidence of major ad-
verse cardiac events was 10.9%, with rates of 6%, 13%, and
20% for 1, 2, and  3 risk factors. In their study, predict-
ability was best for patients aged 55 and improved when
adjusting for age 75 and hypertension. Age was also an
important predictor across the entire VSGNE cohort. Hy-
pertension was significant in the univariate analysis but not
significant in our multivariate testing. The cumulative evi-
dence indicates that age is a key, independent predictor of
adverse cardiac events that must be included in risk predic-
tion before vascular surgery.
Limitations. There are several limitations to our
work. First, there were differences between the VSGNE
and RCRI definitions of composite cardiac end points. We
recorded clinically significant arrhythmias without subclas-
sification, whereas the RCRI included only severe arrhyth-
mias such as ventricular fibrillation and complete heart
block.
Although we also required chest x-ray imaging to doc-
ument CHF, the definition for treatment requirement was
subjective. The stricter definitions of CHF and arrhythmias
used for the RCRI suggest that the RCRI prediction of the
adverse composite outcome would be lower than the VSG-
CRI. In a secondary analysis of MI alone, after excluding
CHF and clinically significant arrhythmias, the RCRI-
predicted event rate closely matched the actual incidence of
postoperative MI. However, the RCRI was originally de-
rived to predict a combined end point of MI, pulmonary
edema, ventricular fibrillation or primary cardiac arrest, and
complete heart block. In addition, inclusion of significant
arrhythmias and CHF is clinically important and common
practice when reporting major adverse cardiac events.
Thus, we believe that the VSG-CRI is a more clinically
accurate predictor for vascular surgery patients.
When we repeated the analysis of the VSG-CRI using
each individual end point (MI, CHF, arrhythmia), our
findings did not significantly change for any of the major
variables in our multivariate model. The positive predictive
value of our model was fairly low (11%). However, this is
likely due to the relatively low incidence of our main
outcomemeasure (6.3% overall) and the relatively common
occurrence of several of the risk factors in our prediction
model, rather than because of poor discrimination of our
model (AUROC curve, 0.71).
Second, we attempted to match the original RCRI
variables, but there were differences, including the substi-
tution of prior CEA as a proxy for a history of cerebrovas-
cular disease and our definition of chronic renal insuffi-
ciency as creatinine 1.8 mg/dL compared with 2.0
mg/dL in RCRI. These differences could bias our results
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ease and overestimating the effect of renal insufficiency, but
the finding of both variables as important predictors in
both models suggests that this is not an important limi-
tation. Also, we did not record the incidence of signifi-
cant cardiac valvular disease, which some have found to
be associated with cardiac morbidity and mortality.1,2,23
We expect these minor differences had little effect on the
overall findings, given the magnitude of difference be-
tween the RCRI-predicted and our observed events. The
preoperative variables that we examined are extensive,
but we cannot account for unmeasured potentially con-
founding variables.
Third, although the comorbidities of our patients are
representative of contemporary vascular surgery practice,
the limited number of nonwhite patients in our cohort may
limit applicability to other patient populations. The VSG-
CRI applies only to nonemergent vascular operations.
Emergency vascular surgery is an independent risk factor
for adverse cardiac events and was excluded from our
analysis.
CONCLUSIONS
The VSG-CRI is more accurate than the RCRI for
predicting composite cardiac complications in patients
undergoing vascular surgery. The VSG-CRI score using
the nine clinical variables of age, smoking, insulin-dependent
diabetes, CAD, CHF, prior CABG or PCI, long-term
-blocker treatment, COPD, and creatinine 1.8 mg/dL
stratifies patients into increasing levels of cardiac risk.
The VSG-CRI may assist clinicians in patient and proce-
dure selection and identify patients in greatest need for
intense efforts at cardiac risk reduction. Comparison of
the VSG-CRI prospectively or within other large registry
databases is necessary to further validate its use in clinical
practice.
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and validation sets
Variable VSGNE derivation set (n  8208) VSGNE validation set (n  1873) Pa
Patient characteristics
Demographics, %
Male gender 65.9 66.2 .808
Age, %
60 16.8 15.9 .351
60-69 29.9 30.3 .715
70-79 37.9 36.4 .245
80 15.5 17.4 .042
Caucasian race 99 97.1 .001
Risk factors, %
Smoking (prior or current) 82.8 83.9 .232
Diabetes
None 66.4 66.8 .781
Non-insulin-dependent 22.1 21.2 .358
Insulin-dependent 11.4 12.1 .436
Hypertension 85.2 87.8 .004
CAD 36.3 32.7 .003
Prior CABG/PCI 32 30.8 .307
CHF 10.9 9.5 .078
Stress test
Not obtained 55.6 59.1 .005
Normal result 30.7 29.3 .23
Abnormal result 13.7 11.6 .014
COPD 28.5 26.9 .168
Chronic renal insufficiency
Creatinine 1.8 mg/dL 8.9 7.4 .059
Dialysis 2.7 2.2 .206
Any prior vascular surgery 29.5 30.9 .227
Prior CEA 11.8 13.1 .135
Medications, %
Aspirin 77.1 84.3 .001
Clopidogrel 12.2 12.1 .892
Statin 64.5 76.4 .001
-blockers
None 17.1 15.7 .124
Perioperative 25.3 24.7 .584
Long-term 57.6 59.7 .099
Operative characteristics
Procedures, No. (%)
CEA 4,267 (52) 1,026 (55) .029
LEB 2,194 (27) 479 (26) .306
EVAR 783 (10) 222 (12) .003
Open infrarenal AAA repair 964 (12) 146 (8) .001
Indications
CEA
Asymptomatic (%) 54 57 .164
Symptomatic (%) 46 43 .164
LEB Claudication (%) 28 30 .546
Critical limb ischemia (%) 72 70 .546
AAA size
5.5 cm 33.5 37.7 .125
5.5-6.0 cm 32.4 35.3 .294
6.0 cm 34.1 27 .009
AAA, Abdominal aortic aneurysm; CABG, coronary artery bypass graft; CAD, coronary artery disease; CEA, carotid endarterectomy; CHF, congestive heart
failure; CLI, critical limb ischemia; COPD, chronic obstructive pulmonary disease; EVAR, endovascular abdominal aortic aneurysm repair; LEB, lower
extremity bypass; OAAA, open infrarenal abdominal aortic aneurysm; PCI, percutaneous coronary intervention.
aP value from 2 test for categoric variables, statistical significance at P  .05.
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Volume 52, Number 3 Bertges et al 683.e2Appendix II (online only). A,Multivariate predictors of composite cardiac outcome for Vascular Surgery Group of New
England (VSGNE) derivation cohort (2003-2007) including aggregate, carotid endarterectomy (CEA), endovascular
aneurysm repair (EVAR), lower extremity bypass (LEB), and open infrarenal abdominal aortic aneurysm (OAAA)models
Variable
Aggregrate model
(n  8208 ) CEA (n  4267) LEB (n  2194) EVAR (n  783) OAAA (n  964)
OR 95% CI P OR 95% CI P OR 95% CI P OR 95% CI P OR 95% CI P
Female . . . . . . . . . . . . . . . . . . 1.4 1.0-2.0 .84 . . . . . . . . . . . . . . . . . .
Age . . . . . . .001 . . . . . . . . . . . . . . . .02 . . . . . . . . . . . . . . . .02
60 Ref . . . . . . . . . . . . . . . Ref . . . . . . . . . . . . . . . Ref . . . . . .
60-69 1.7 1.2-2.4 .03 . . . . . . . . . 1.5 0.9-2.6 .161 . . . . . . . . . 3.2 1.2-8.3 .19
70-79 2.1 1.5-3.0 .001 . . . . . . . . . 1.8 1.1-3.1 .24 . . . . . . . . . 4.2 1.6-10.8 .03
80 2.8 2.0-4.1 .001 . . . . . . . . . 2.8 1.6-5.0 .001 . . . . . . . . . 6.1 2.2-16.1 .01
Smoking 1.3 1.0-1.8 .41 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Diabetes . . . . . . .40 . . . . . . .03 . . . . . . .75 . . . . . . . . . . . . . . . . . .
None Ref . . . . . . Ref Ref . . . . . . . . . . . . . . . . . . . . . . . .
Non-insulin
dependent
1.0 0.8-1.3 .953 1.2 0.8-1.9 .440 1.5 1.0-2.2 .66 . . . . . . . . . . . . . . . . . .
Insulin-
dependent
1.4 1.1-1.9 .14 2.4 1.5-4.0 .01 1.6 1.0-2.4 .37 . . . . . . . . . . . . . . . . . .
CAS 1.4 1.2-1.8 .01 2.3 1.5-3.6 .001 . . . . . . . . . . . . . . . . . . . . . . . . . . .
CABG/PCI 0.8 0.7-1.0 .38 0.5 0.3-0.8 .04 . . . . . . . . . . . . . . . . . . 0.7 0.5-1.0 .62
CHF 1.9 1.5-2.5 .001 2.5 1.5-4.0 .001 2.0 1.4-2.9 .001 3.6 1.7-7.6 .01 1.8 1.0-3.1 .53
COPD 1.6 1.3-1.9 .001 . . . . . . . . . 1.7 1.2-2.4 .02 . . . . . . . . . 1.7 1.2-2.4 .01
Creatinine
1.8
mg/dL
1.7 1.3-2.2 .001 . . . . . . . . . . . . . . . . . . . . . . . . . . . 2.3 1.4-3.7 .02
Cardiac stress
test
. . . . . . .001 . . . . . . .16 . . . . . . .06 . . . . . . .143 . . . . . . . . .
Normal
result
Ref Ref . . . . . . . . . . . . Ref . . . . . . . . . . . . . . .
Not done 0.6 0.5-0.7 .001 1.2 0.8-2.0 .413 0.7 0.5-1.1 .101 0.9 0.4-2.2 .876 . . . . . . . . .
Abnormal
result
1.2 1.0-1.6 .115 2.2 1.2-3.8 .07 1.4 0.9-2.3 .167 2.1 0.8-5.5 .131 . . . . . . . . .
Aspirin . . . . . . . . . 2.4 1.2-4.8 .14 . . . . . . . . . . . . . . . . . . . . . . . . . . .
Clopidogrel . . . . . . . . . 1.6 1.0-2.5 .32 . . . . . . . . . 4.4 1.6-11.7 .04 . . . . . . . . .
Statin . . . . . . . . . 0.6 0.4-0.9 .11 1.3 0.9-1.8 0.166 . . . . . . . . . . . . . . . . . .
-Blockers . . . . . . .24 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .01
None Ref . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Ref . . . . . .
Perioperative 1.0 0.8-1.4 .817 . . . . . . . . . . . . . . . . . . . . . . . . . . . 1.0 0.6-2.0 .908
Chronic 1.4 1.0-1.8 .36 . . . . . . . . . . . . . . . . . . . . . . . . . . . 2.1 1.1-3.7 .16
Prior vascular
surgery
. . . . . . . . . 1.6 1.1-2.4 .20 . . . . . . . . . . . . . . . . . . 1.8 1.1-2.7 .11
AAA size, cm . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .35
5.5 . . . . . . . . . . . . . . . . . . . . . . . . . . . Ref . . . . . .
5.5-6.0 . . . . . . . . . . . . . . . . . . . . . . . . . . . 2.9 1.0-8.2 .44
6.0 . . . . . . . . . . . . . . . . . . . . . . . . . . . 4.0 1.4-11.3 .10
Critical limb
ischemia
. . . . . . . . . . . . . . . . . . 1.9 1.2-3.1 .012 . . . . . . . . . . . . . . . . . .
AAA, abdominal aortic aneurysm; CABG, coronary artery bypass graft; CAD, coronary artery disease; CHF, congestive heart failure; CLI, critical limb
ischemia; COPD, chronic obstructive pulmonary disease; PCI, percutaneous coronary intervention; Ref, reference group.
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Model
Derivation set Validation set
AUROC P AUROC P
Aggregate 0.71 .580 0.66 .161
CEA 0.74 .604 0.65 .766
LEB 0.72 .882 0.72 .280
EVAR 0.74 .179 0.69 .786
OAAA 0.68 .979 0.73 .856
AUROC, Area under receiver operating characteristic curve; CEA, carotid endarterectomy; CHF, congestive heart failure; EVAR, endovascular abdominal
aortic aneurysm repair; LEB, lower extremity bypass; OAAA, open Infrarenal abdominal aortic aneurysm.
P values by Hosmer and Lemeshow goodness-of-fit test.
Appendix IV (online only). Sensitivity, specificity, positive predictive value, (PPV) and negative predictive value (NPV) for
the aggregate and four procedure-specific models
Model AUC Cut-point Sensitivity (%) Specificity (%) PPV (%) NPV (%)
Aggregate 0.71 0.06 67.6 62.4 11.2 96.5
CEA 0.74 0.04 45.5 83.1 7.3 98.1
LEB 0.72 0.08 67.1 64.4 14.3 95.7
EVAR 0.74 0.06 51.4 81.4 12.5 97.0
OAAA 0.68 0.22 51.6 70.6 30.2 85.6
AUC, Area under curve; CEA, carotid endarterectomy; Cut-point, optimal cut-point; EVAR, endovascular abdominal aortic aneurysm repair; LEB, lower
extremity bypass; OAAA, open infrarenal abdominal aortic aneurysm.
Model Aggregate CEA LEB EVAR OAAA 
ICC 0.99 0.94 0.99 0.97 0.98 
AAA Model
r2 = 0.9483
LEB Model
r2 = 0.986
Aggregate Model
r2 = 0.9862
EVAR Model
r2 = 0.9581
CEA Model
r2 = 0.9298
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Appendix III (online only). Quintiles of observed versus expected risk for aggregate and procedure-specific models.
CEA, carotid endarterectomy; EVAR, endovascular abdominal aortic aneurysm repair; LEB, lower extremity bypass;
ICC, interclass correlation; OAAA, open Infrarenal abdominal aortic aneurysm.
